Issue navigation
Volume 15, Issue 4, April 2021
Editorial
Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet?
Mohammed Nabil Quraishi and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 519–520, https://doi.org/10.1093/ecco-jcc/jjaa190
Original Articles
An Anti-migration Self-expandable and Removable Metal Stent for Crohn’s Disease Strictures: A Nationwide Study From GETAID and SFED
Alain Attar and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 521–528, https://doi.org/10.1093/ecco-jcc/jjaa208
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
Lauranne A A P Derikx and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 529–539, https://doi.org/10.1093/ecco-jcc/jjaa215
Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease—A Danish Prospective Population-based Cohort Study
Mohamed Attauabi and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 540–550, https://doi.org/10.1093/ecco-jcc/jjaa205
Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis
Fernando Magro and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 551–566, https://doi.org/10.1093/ecco-jcc/jjaa176
Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment Endpoint
Sushrut Jangi and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 567–574, https://doi.org/10.1093/ecco-jcc/jjaa184
Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn’s Disease: a Nationwide Cohort Study
Ken Lund and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 575–582, https://doi.org/10.1093/ecco-jcc/jjaa188
Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn’s Disease
Danny Con and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 583–593, https://doi.org/10.1093/ecco-jcc/jjaa194
Disease Activity Patterns, Mortality, and Colorectal Cancer Risk in Microscopic Colitis: A Danish Nationwide Cohort Study, 2001 to 2016
Petra Weimers and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 594–602, https://doi.org/10.1093/ecco-jcc/jjaa207
Variability in the Distribution of Histological Disease Activity in the Colon of Patients with Ulcerative Colitis
Peter Bossuyt and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 603–608, https://doi.org/10.1093/ecco-jcc/jjaa206
Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn’s Disease
Kerri L Novak and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 609–616, https://doi.org/10.1093/ecco-jcc/jjaa216
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis
Leonie C S De Vries and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 617–630, https://doi.org/10.1093/ecco-jcc/jjaa199
Chylomicrons-Simulating Sustained Drug Release in Mesenteric Lymphatics for the Treatment of Crohn’s-Like Colitis
Yi Yin and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 631–646, https://doi.org/10.1093/ecco-jcc/jjaa200
miR-130a-3p, a Preclinical Therapeutic Target for Crohn’s Disease
Jie Zhao and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 647–664, https://doi.org/10.1093/ecco-jcc/jjaa204
M2 Macrophage-Derived Exosomal miR-590-3p Attenuates DSS-Induced Mucosal Damage and Promotes Epithelial Repair via the LATS1/YAP/ β-Catenin Signalling Axis
Feihong Deng and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 665–677, https://doi.org/10.1093/ecco-jcc/jjaa214
Review Article
Crohn’s Disease: Is the Cold Chain Hypothesis Still Hot?
Jean-Pierre Hugot and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 678–686, https://doi.org/10.1093/ecco-jcc/jjaa192
Short Report
Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [PIMS-TS] in a Patient Receiving Infliximab Therapy for Inflammatory Bowel Disease
Joseph Meredith and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 687–691, https://doi.org/10.1093/ecco-jcc/jjaa201
Letters to the Editor
Tofacitinib and Subacute Pneumonitis: Don’t Hold Your Breath
Bram Verstockt and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Pages 692–693, https://doi.org/10.1093/ecco-jcc/jjaa218
Tofacitinib Therapy, the Lender of Last Resort
Mariann Rutka and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Page 694, https://doi.org/10.1093/ecco-jcc/jjaa198
Use of Tofacitinib for Ulcerative Colitis in a Liver Transplant Patient
Lucy Meunier and others
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Page 695, https://doi.org/10.1093/ecco-jcc/jjaa032
Corrigendum
A Corrigendum
Journal of Crohn's and Colitis, Volume 15, Issue 4, April 2021, Page 696, https://doi.org/10.1093/ecco-jcc/jjaa264
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals